Entero Therapeutics (ENTO) will change its name to GridAI (GRDX) Technologies Corp., effective at 12:01 Eastern Time on Monday, December 1, 2025. The name change closely aligns the Company’s business following its acquisition of 100% of GRID AI, a grid-edge, AI-driven software and controls platform that enables utilities, retail energy providers, and large power users to dynamically manage load and distributed energy resources including battery energy storage systems. In connection with the name change, the Company will change its ticker symbol to “GRDX”. The Company’s common stock will commence trading on the Nasdaq Capital Market exchange under the new name and trading symbol on December 1, 2025. The name and future ticker change do not affect the Company’s legal structure, business operations, or existing financial reporting obligations. Shareholders are not required to take any action in connection with the change.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ENTO:
- NASDAQ: ENTO’s Grid AI Strikes Texas Hyperscale Deal as its $50M Industrial Software Platform Enters the AI Race
- Entero Therapeutics’ Grid AI enter LOI with AI data-center customer
- Entero Therapeutics Delays Q3 10-Q Filing
- Entero Therapeutics’ Grid AI finalizing establishment of U.S. leadership team
- Entero Therapeutics’ Board Governance Structure Update